Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,450 GBX | -0.13% | -1.08% | +17.49% |
10:03am | AstraZeneca: Farxiga approved for diabetes as of age 10 | CF |
05:56am | AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.49% | 248B | |
+48.79% | 781B | |
+41.67% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+0.12% | 221B | |
+11.33% | 217B | |
+4.53% | 162B | |
-3.92% | 157B | |
-1.13% | 121B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents